NFKB1 and atherosclerosis: MiR-146a-3p may suppress inflammation by targeting NF-κB during the progression of atherosclerosis, and the miR-146a-3p/NF-κB axis could serve as a promising biomarker and therapeutic target for preventing atherosclerosis and associated vascular events.